TrialThe Lancet. Infectious diseases2026

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.

Tamiru Shibiru Degaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.